Methacholine Challenge Caveats, Biologic Super-Responders

| June 7, 2021

Methacholine Challenge Caveats, Biologic Super-Responders

For today’s episode we will be reviewing articles from the November-December 2020 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. You can also earn CME credit by listening to this podcast! For information about CME credit or to read archived issues of Allergy Watch, head over to

Please watch out for continued discussion on this topic in the ACAAI Community on DocMatter, we’ll have key talk takeaways and an engaging question with the opportunity for ongoing conversation about today’s topic!

Article Links:
Understanding the asthmatic response to an experimental rhinovirus infection: Exploring the effects of blocking IgE

Performance Characteristics of Spirometry With Negative Bronchodilator Response and Methacholine Challenge Testing and Implications for Asthma Diagnosis

Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma

Please rate our podcast on iTunes!

Please give us feedback, corrections, and suggestions!

Email feedback to:

Today’s speakers have the following disclosures:
Dr. Lee has nothing to disclose.
Dr. Kalangara – Speaker and Consultant: GlaxoSmithKline
Dr. Fineman – Speaker: Takeda; Research: Aimmune, DBV, Biocryst

We’re pleased to introduce CME credit for this episode of AllergyTalk! Get credit for this episode.

ACAAI presents this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to the procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that may be referenced.